Sample Size and Statistical Power Calculation in Genetic Association Studies

다국어 초록 (Multilingual Abstract)

A sample size with sufficient statistical power is critical to the success of genetic association studies to detect causal genes of human complex diseases. Genome-wide association studies require much larger sample sizes to achieve an adequate statistical power. We estimated the statistical power with increasing numbers of markers analyzed and compared the sample sizes that were required in case-control studies and case-parent studies. We computed the effective sample size and statistical power using Genetic Power Calculator. An analysis using a larger number of markers requires a larger sample size.
Testing a single-nucleotide polymorphism (SNP) marker requires 248 cases, while testing 500,000 SNPs and 1 million markers requires 1,206 cases and 1,255 cases, respectively, under the assumption of an odds ratio of 2, 5% disease prevalence, 5%minor allele frequency, complete linkage disequilibrium (LD), 1：1 case/control ratio, and a 5% error rate in an allelic test.
Under a dominant model, a smaller sample size is required to achieve 80% power than other genetic models. We found that a much lower sample size was required with a strong effect size, common SNP, and increased LD. In addition, studying a common disease in a case-control study of a 1：4 case-control ratio is one way to achieve higher statistical power. We also found that case-parent studies require more samples than case-control studies. Although we have not covered all plausible cases in study design, the estimates of sample size and statistical power computed under various assumptions in this study may be useful to determine the sample size in designing a population-based genetic association study.

참고문헌 (Reference)

1 박애경, "유전체 연관 연구에서의 검정력 및 연구대상수 계산 고찰" 대한예방의학회 40 (40): 114-121, 2007

2 Buyske S, "When a case is not a case: effects of phenotype misclassification on power and sample size requirements for the transmission disequilibrium test with affected child trios" 67 : 287-292, 2009

3 Satagopan JM, "Two-stage designs for gene-disease association studies with sample size constraints" 60 : 589-597, 2004

4 Risch N, "The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling" 8 : 1273-1288, 1998

5 Whitley E, "Statistics review 4: sample size calculations" 6 : 335-341, 2002

6 Wu Z, "Statistical power of model selection strategies for genome-wide association studies" 5 : 1000582-, 2009

7 Houle TT, "Statistical power and sample size estimation for headache research: an overview and power calculation tools" 45 : 414-418, 2005

8 Risch NJ, "Searching for genetic determinants in the new millennium" 405 : 847-856, 2000

9 Liu X, "Sample size determination for classifiers based on single-nucleotide polymorphisms" 13 : 217-227, 2012

10 Pfeiffer RM, "Sample size calculations for populationand family-based case-control association studies on marker genotypes" 25 : 136-148, 2003

11 Ahn Chul, "Sample Size and Power Estimation in Case-ControlGenetic Association Studies" 한국유전체학회 4 (4): 51-56, 2006

12 Laurie CC, "Quality control and quality assurance in genotypic data for genome-wide association studies" 34 : 591-602, 2010

13 Gordon D, "Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms" 54 : 22-33, 2002

14 Klein RJ, "Power analysis for genome-wide association studies" 8 : 58-, 2007

15 Peng B, "Power analysis for case-control association studies of samples with known family histories" 127 : 699-704, 2010

16 Hindorff LA, "Potential etiologic and functional implications of genome-wide association loci for human diseases and traits" 106 : 9362-9367, 2009

17 Menashe I, "PGA: power calculator for case-control genetic association analyses" 9 : 36-, 2008

18 Comeron JM, "On the power to detect SNP/phenotype association in candidate quantitative trait loci genomic regions: a simulation study" 8 : 478-489, 2003

19 Hirschhorn JN, "Genomewide association studies: illuminating biologic pathways" 360 : 1699-1701, 2009

20 Lunetta KL, "Genetic association studies" 118 : 96-101, 2008

21 Purcell S, "Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits" 19 : 149-150, 2003

22 박주현, "Estimation of effect size distribution from genome-wide association studies and implications for future discoveries" NATURE PUBLISHING GROUP 42 (42): 570-139, 201007

23 Gordon D, "Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies" 490 : 501-, 2003

24 Spencer CC, "Designing genome- wide association studies: sample size, power, imputation, and the choice of genotyping chip" 5 : 1000477-, 2009

25 Zondervan KT, "Designing candidate gene and genome- wide case-control association studies" 2 : 2492-2501, 2007

26 Scherag A, "Data adaptive interim modification of sample sizes for candidate- gene association studies" 56 : 56-62, 2003

27 Cardon LR, "Association study designs for complex diseases" 2 : 91-99, 2001

28 Hintsanen P, "An empirical comparison of case-control and trio based study designs in high throughput association mapping" 43 : 617-624, 2006

29 Hirschhorn JN, "A comprehensive review of genetic association studies" 4 : 45-61, 2002

30 Van den Oord EJ, "A comparison between different designs and tests to detect QTLs in association studies" 29 : 245-256, 1999

31 Manolio TA, "A HapMap harvest of insights into the genetics of common disease" 118 : 1590-1605, 2008